( Tygacil (tigecycline)is a new expanded...)Broad Spectrum Antibiotic Available for Antibiotic Resistant Bacteria,Health

Tygacil (tigecycline)is a new, expanded broad-spectrum IV antibiotic that can be used for the treatment of a wide range of infections including those caused by antibiotic// resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA). It will be available in the UK from today. Availability of this new antibiotic comes at a time when the need for effective new treatments is greater than ever and clinicians are running out of options.

"Difficult to treat, antibiotic-resistant and often life-threatening infections are a growing problem in the UK, costing the NHS an estimated additional ￡1 billion annually," says Dr Robert Masterton, Executive Medical Director and Consultant Microbiologist, NHS Ayrshire & Arran, "Even more worrying has been the emergence of the organisms commonly called 'superbugs' – those very worrying bacteria that have become resistant to a large number and in some cases all available antibiotics. Add to this the diminishing development of new antibiotics in the last 20 years and we could soon see a return to the Florence Nightingale era where infections caused more death than bullets because there were no effective drugs to treat these diseases. The introduction of tigecycline in the UK comes at absolutely the right time and will provide a vital new weapon in the fight against infection."

Tigecycline has been licensed for use in the UK as a treatment for a variety of complicated skin and soft tissue infections including infected wounds and complicated intra- abdominal infections such as complicated appendicitis.1 It is the world's first glycylcycline and has been developed by Wyeth to overcome two common mechanisms of resistance that have reduced the efficacy and limited the use of certain existing antibiotics.

While MRSA has received wide media and government attention and concern in the UK, other infections like Escherichia Coli (E. Coli) and Klebsiella could pose an even greater risk to public
'"/>




Page: 1 2
Related medicine news :

1. Tigecycline – New Generation Tetracycline With Broad Spectrum Antibacterial Activit
2. Plan To Connect Remote Aboriginal Communities Through Broadband
3. Low Doses Of Arsenic Have Broad Impact On Hormone Activity – Says A Researc
4. FDA Announces Audio Broadcasts on Emerging Drug Safety Information
5. Tigecycline – New Generation Tetracycline With Broad Spectrum Antibacterial Activit
6. Simple Eye Movement Test For Early Detection Of Fetal Alcohol Spectrum Disorder
7. Lack Of Social Skills Linked To Autism Spectrum Disorder (ASD)
8. Fetal Alcohol Spectrum Disorder in Children Can Be Diagnosed With Eye Movement Tests
9. Younger Siblings of Children With Autism Spectrum Disorders Score Low
10. Antibiotics Dangerous for Diarrhoea in Children Caused by E.Coli
11. Antibiotics Helps Autism